KLC1 and Parkinson disease: For example, in rats afflicted with parkinsonism [30, 31] and in patients afflicted with ALS [32] and Alzheimer's disease, the content of kinesin reduces [33]; however, the KLC1 level in patients with breast cancer was witnessed to be remarkably increasing [34].